SWOG clinical trial number
SWOG-7904

Hexamethylmelamine vs FAC in Advanced Transitional Cell Bladder Carcinoma in Patients with Impaired Renal Function

Closed
Phase
Abbreviated Title
Hexamethylmelamine vs FAC in Advanced Transitional Cell Bladder Carcinoma in Patients with Impaired Renal Function
Activated
04/17/1979
Closed
09/10/1982

Publication Information Expand/Collapse

1984

A randomized trial of Hexamethylmelamine versus 5-FU, doxorubicin and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: A Southwest Oncology Group study.

RG Gagliano;RL Stephens;JJ Costanzi;N Oishi;WJ Stuckey;PN Grozea;J Frank;ED Crawford Cancer Treat Rep 68:1025-1026

1983

Hexamethylmelamine (HEX) vs. Flourouracil, Adriamycin and Cytoxan (FAC) in advanced bladder cancer - A SWOG study.

ED Crawford;R Gagliano;J Frank ASCO #C-518